Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms
Authors
Keywords
HBV, HCC, HBx-HepG2, 5-FU, Cisplatin, Chemo-resistance, HIF-1α, P-gp, MRP1, LRP
Journal
Cancer Cell International
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-12
DOI
10.1186/s12935-015-0269-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma
- (2015) Myeong Jun Song et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- New Frontiers in Promoting TRAIL-Mediated Cell Death: Focus on Natural Sensitizers, miRNAs, and Nanotechnological Advancements
- (2015) Ammad Ahmad Farooqi et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma
- (2015) Chengli Du et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia
- (2015) Meng-Chuan Chen et al. Marine Drugs
- Regulation of Multidrug Resistance Proteins by Genistein in a Hepatocarcinoma Cell Line: Impact on Sorafenib Cytotoxicity
- (2015) Juan Pablo Rigalli et al. PLoS One
- Restoring TRAIL Mediated Signaling in Ovarian Cancer Cells
- (2014) Ammad Ahmad Farooqi et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells
- (2014) Sundas Fayyaz et al. MOLECULAR BIOLOGY REPORTS
- Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation
- (2014) Bo Zhai et al. TUMOR BIOLOGY
- Breast Cancer Proteome Takes More Than Two to Tango on TRAIL: Beat Them at Their Own Game
- (2012) Ammad Ahmad Farooqi et al. JOURNAL OF MEMBRANE BIOLOGY
- Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
- (2012) Nanduri R. Prabhakar et al. PHYSIOLOGICAL REVIEWS
- Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms
- (2011) Dianfeng Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2
- (2011) Xiaosong Wu et al. CANCER BIOLOGY & THERAPY
- Hypoxia and hypoxia inducible factors: Diverse roles in liver diseases
- (2011) Bharath Nath et al. HEPATOLOGY
- Hypoxia and mitochondrial oxidative metabolism
- (2010) Giancarlo Solaini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- The protective role of 5-HMF against hypoxic injury
- (2010) Ming-Ming Li et al. CELL STRESS & CHAPERONES
- Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways
- (2008) P. Lunghi et al. BLOOD
- Arsenic Trioxide Sensitizes Human Glioma Cells, but not Normal Astrocytes, to TRAIL-Induced Apoptosis via CCAAT/Enhancer-Binding Protein Homologous Protein Dependent DR5 Up-regulation
- (2008) E. H. Kim et al. CANCER RESEARCH
- Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria
- (2008) Hye Jin Kim et al. IUBMB LIFE
- Arsenic trioxide mechanisms of action – looking beyond acute promyelocytic leukemia
- (2008) Dennis A. Carney LEUKEMIA & LYMPHOMA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started